PL360848A1 - Kahalalid F - Google Patents

Kahalalid F

Info

Publication number
PL360848A1
PL360848A1 PL36084801A PL36084801A PL360848A1 PL 360848 A1 PL360848 A1 PL 360848A1 PL 36084801 A PL36084801 A PL 36084801A PL 36084801 A PL36084801 A PL 36084801A PL 360848 A1 PL360848 A1 PL 360848A1
Authority
PL
Poland
Prior art keywords
kahalalide
formulation
formulations
Prior art date
Application number
PL36084801A
Other languages
English (en)
Other versions
PL203676B1 (pl
Inventor
Glynn Thomas Faircloth
Bastian Nuyen
Steve Weitman
Original Assignee
Pharma Mar, S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharma Mar, S.A. filed Critical Pharma Mar, S.A.
Publication of PL360848A1 publication Critical patent/PL360848A1/pl
Publication of PL203676B1 publication Critical patent/PL203676B1/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/15Depsipeptides; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Carbon And Carbon Compounds (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Liquid Crystal Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
PL360848A 2000-10-31 2001-10-31 Liofilizowany preparat kahalalidu F, zestaw, odtworzony roztwór i zastosowanie PL203676B1 (pl)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US24447100P 2000-10-31 2000-10-31
US60/244,471 2000-10-31
US24622900P 2000-11-06 2000-11-06
US60/246,229 2000-11-06
US34844901P 2001-10-19 2001-10-19
US60/348,449 2001-10-19
PCT/GB2001/004821 WO2002036145A2 (en) 2000-10-31 2001-10-31 Kahalalide f formulation

Publications (2)

Publication Number Publication Date
PL360848A1 true PL360848A1 (pl) 2004-09-20
PL203676B1 PL203676B1 (pl) 2009-10-30

Family

ID=

Also Published As

Publication number Publication date
WO2002036145A8 (en) 2003-10-23
JP2010047601A (ja) 2010-03-04
ATE314084T1 (de) 2006-01-15
HUP0600031A3 (en) 2012-02-28
DK1330258T3 (da) 2006-05-22
NO20031860L (no) 2003-06-30
EP1330258A2 (en) 2003-07-30
HK1054192A1 (en) 2003-11-21
MXPA03003704A (es) 2004-05-04
AU1074902A (en) 2002-05-15
BR0114912A (pt) 2003-10-14
CA2425627A1 (en) 2002-05-10
SK5022003A3 (en) 2003-12-02
WO2002036145A2 (en) 2002-05-10
IL155297A (en) 2010-05-31
EP1330258B1 (en) 2005-12-28
CY1105009T1 (el) 2010-03-03
IL155297A0 (en) 2003-11-23
CZ20031211A3 (cs) 2003-09-17
AU2002210749B2 (en) 2006-12-21
JP2004512370A (ja) 2004-04-22
US7473681B2 (en) 2009-01-06
SK286421B6 (sk) 2008-09-05
NZ525243A (en) 2005-01-28
HUP0600031A2 (en) 2006-05-29
KR20030044005A (ko) 2003-06-02
NO20031860D0 (no) 2003-04-25
KR100834138B1 (ko) 2008-06-02
WO2002036145A3 (en) 2002-10-17
DE60116359T2 (de) 2006-09-28
ES2256305T3 (es) 2006-07-16
HK1054192B (en) 2006-09-08
DE60116359D1 (de) 2006-02-02
US20040067895A1 (en) 2004-04-08
CN1568192A (zh) 2005-01-19
NO331082B1 (no) 2011-10-03

Similar Documents

Publication Publication Date Title
IL155297A0 (en) Kahalalide f formulation
MXPA03005769A (es) Politrimetilen eter ester amida y uso de la misma.
WO2001070275A3 (en) Polyglutamic acid-camptothecin conjugates and methods of preparation
AU144678S (en) Bottle
PT1412384E (pt) Formulação estável de glp-1 modificado
IL153115A0 (en) Angiogenesis-modulating compositions and uses
PH12001001235B1 (en) Novel surfactants and formulations
AU5002301A (en) Cosmetic compositions comprising exfoliating enzymes and uses thereof
SG148031A1 (en) Use of cci-779 as an antineoplastic agent
MXPA02012937A (es) Combinaciones de productos activos con propiedades insecticidas y acaricidas.
AU2001247486A1 (en) Hair restoration formulation
AU3227700A (en) Skin sanitizing compositions
GB0101035D0 (en) Formulation and use thereof
AU2001272615A1 (en) Amphipathic linear peptides and compositions containing same
AU2001292047A1 (en) Composition containing an azaphthalocyanine and use
AU2002218195A1 (en) Silicone rubber formulations and the use thereof
AU2002251801A1 (en) Composition containing hedychium extract and use thereof
MY133881A (en) "calcilytic compounds"
AU2001279729A1 (en) Use of cross-linker and compositions made therefrom
MXPA02007173A (es) Compuestos calciliticos.
EP1383511A4 (en) CALCILYTIC COMPOUNDS
AU2001297556A1 (en) 38650, 28472, 5495, 65507, 81588 and 14354 methods and compositions of human proteins and uses thereof
AU2001271281A1 (en) Novel compositions for the expression of the human peptide histidine transporter1 and methods of use thereof
AU7655600A (en) 1,4-dioxacycloalkane-2-one and 1,4-dioxacycloalkene-2-one
AUPQ760400A0 (en) Herbical formulations and methods of use thereof